SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

http://www.nasdaq.com/symbol/ino/after-hours

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Banks Member Profile
 
Followed By 56
Posts 10,988
Boards Moderated 0
Alias Born 05/02/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2017 4:25:23 PM
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study "GlobeNewswire Inc." - 5/24/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/16/2017 4:07:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:35:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:29:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:18:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:15:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:15:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:14:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:14:04 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2017 3:44:20 PM
Inovio Provides Update on MedImmune Launch of Combination Trial for HPV-associated Head & Neck Cancer "GlobeNewswire Inc." - 5/10/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/9/2017 7:45:32 PM
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy "PR Newswire (US)" - 5/8/2017 7:30:00 AM
Inovio & Regeneron Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy "GlobeNewswire Inc." - 5/8/2017 7:30:00 AM
Inovio Pharmaceuticals to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference "GlobeNewswire Inc." - 5/2/2017 8:00:00 AM
Inovio Pharmaceuticals to Report First Quarter 2017 Financial Results May 10, 2017 "GlobeNewswire Inc." - 4/26/2017 8:00:00 AM
Inovio Initiates Phase 2 Efficacy Trial with VGX-3100 For HPV-Related Vulvar Pre-Cancers "GlobeNewswire Inc." - 4/24/2017 8:00:00 AM
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial "GlobeNewswire Inc." - 4/11/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 5:10:41 PM
Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to Induce Remission of HI... "GlobeNewswire Inc." - 3/30/2017 8:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/29/2017 4:36:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/28/2017 2:44:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/24/2017 4:08:24 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/23/2017 4:18:20 PM
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist